Abstract:The current issue of Seminars in Liver Disease is devoted to contemporary issues of hepatic pathology. In this era of rapid medical advances, pathology continues to play a very important role in the diagnosis and the assessment of severity of common and rare diseases, and to provide the interface between basic and clinical research. The biologic nature and clinical course of a variety of diseases are still elucidated by histopathologic study and clinicopathologic correlation, while the discovery of new immunohistochemical markers provides additional tools for research and diagnosis. Furthermore, understanding the pathologic basis of diseases is a prerequisite for a meaningful understanding of the corresponding molecular changes, clinical manifestations, and radiologic features, and for planning appropriate treatments. In this issue of Seminars, Morotti and collaborators from the Departments of Pathology and Pediatrics at The Mount Sinai Medical Center in New York City review the pathologic findings of progressive familial intrahepatic cholestasis (PFIC) type 1, 2, and 3, which represent recently characterized conditions that are due to mutations in specific genes involved in bile acid formation and transport. Electron microscopy and recently developed immunohistochemical markers are useful in the diagnosis of these disorders. Fabris and Strazzabosco from the Department of Surgical and Gastroenterological Sciences of the University of Padova and from the Department of Internal Medicine of Yale University provide an in-depth review of the properties of the different cell types and mediators involved in the epithelial–mesenchymal interactions occurring in biliary diseases, and analyze the molecular mechanisms underlying this cross-talk as they relate to liver repair. Tsui and collaborators from the Departments of Pathology, Medicine and Geriatrics, and Radiology of Caritas Medical Centre in Hong Kong provide a fresh look at hepatolithiasis (also known as recurrent pyogenic cholangitis), a disease that is increasingly encountered outside of endemic areas, due to global migration. The authors discuss the radiologic and histologic features that are important in the diagnosis and differential diagnosis of this condition, and emphasize the importance of a multidisciplinary team approach for optimal patient outcome. Sempoux from the Department of Pathology of the Saint Luc University Clinics in Brussels and collaborators from the Departments of Surgery and Pathology at The Mount Sinai Medical Center review their extensive experience with intrahepatic peripheral cholangiocarcinoma, and provide evidence suggesting that cholangiocarcinomas with unusual (“nonclassical”) histologic features may often be related to chronic hepatitis C infection. Ward and Waxman from the Departments of Pathology and Medicine at The Mount Sinai Medical Center review the features of the fibrolamellar variant of hepatocellular carcinoma, a neoplasm with enigmatic etiology, emphasizing the genomic alterations, which appear to be fewer and less frequent than those of other hepatic malignancies, such as classic hepatocellular carcinoma, cholangiocarcinoma, and hepatoblastoma. Guido and Burra from the Pathology Unit and the Department of Gastroenterological and Surgical Sciences of the University of Padova review the pathologic and clinical features of de novo autoimmune hepatitis, a recently recognized disease occurring in liver allografts. Diagnosis of this serious disorder of obscure pathogenesis is often challenging, and requires careful clinicopathologic correlation. Germani and collaborators from the Departments of Surgery and Pathology of the Royal Free Hospital in London and from the Department of Pathology of the Aristotle University of Thessaloniki provide an update regarding the assessment of fibrosis in liver biopsy specimens. Although histologic examination remains the gold standard for staging chronic liver diseases, quantitative assessment of hepatic fibrosis by image analysis holds promise as a prognostic marker, and as a means to validate noninvasive markers of fibrosis. Last, but not least, Bioulac-Sage and collaborators from the Department of Pathology of the University of Bordeaux 2 and from Genomique Fonetionnelle des Tumeurs Solides in Paris revisit the pathology of benign hepatocellular nodules using novel immunohistochemical markers, derived from molecular studies. Their methodology allows the identification of clinically relevant subtypes of hepatocellular adenoma, as well as the differential diagnosis between unusual cases of focal nodular hyperplasia and hepatocellular adenoma. We are thankful to the authors for sharing their knowledge and experience with the readers of this issue of Seminars. We sincerely hope that this issue will be useful for pathologists, clinicians, and other scientists involved in the diagnosis, treatment, and research of hepatic diseases.

Hepatology Highlights

A Single‐Cell Perspective of the Mammalian Liver in Health and Disease

HBPD: Table of Contents Vol. 7, No. 4, 2008

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

Select Toxicologic Pathology Case Studies of the Hepatobiliary System

Editorial: Diagnosis, Treatment and Prognosis of Viral Hepatitis, Volume II.

Advances in Hepatitis B Treatment

Contemporary Issues in Liver Pathology

Acute-on-chronic Liver Failure in Chronic Hepatitis B: an Update.

Advances in Endohepatology

Prevention in Hepatology

Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

Single-cell technologies in hepatology: new insights into liver biology and disease pathogenesis

Editorial: liver test abnormalities in oncology patients in the age of the checkpoint inhibitors

Alcoholic hepatitis: Translational approaches to develop targeted therapies

[Recent Advances in the Treatment of Hepatitis C in 2016].

Summary of Candidate Selection and Expanded Criteria for Liver Transplantation for Hepatocellular Carcinoma: A Review and Consensus Statement

Advances in treatment and prevention of hepatitis B

Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies

Endohepatology: Arrival at the frontier of interventional endosonography

Emerging Pharmacologic Treatments for Alcohol-Associated Hepatitis: Current Status and Future Landscape